# Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

> **NCT06822166** · PHASE1 · COMPLETED · sponsor: **Ahon Pharmaceutical Co., Ltd.** · enrollment: 68 (actual)

## Conditions studied

- Interaction Drug Food

## Interventions

- **DRUG:** rifampicin
- **DRUG:** Fluconazole
- **DRUG:** Omeprazole
- **DRUG:** midazolam
- **DRUG:** ET-26

## Key facts

- **NCT ID:** NCT06822166
- **Lead sponsor:** Ahon Pharmaceutical Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-04
- **Primary completion:** 2024-01-23
- **Final completion:** 2024-01-23
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822166, "Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06822166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*